Zrihan-Licht S, Baruch A, Elroy-Stein O, Keydar I, Wreschner D H
Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Israel.
FEBS Lett. 1994 Dec 12;356(1):130-6. doi: 10.1016/0014-5793(94)01251-2.
Phosphorylation on tyrosine residues is a key step in signal transduction pathways mediated by membrane proteins. Although it is known that human breast cancer tissue expresses at least 2 MUC1 type 1 membrane proteins (a polymorphic high molecular weight MUC1 glycoprotein that contains a variable number of tandem 20 amino acid repeat units, and the MUC1/Y protein that is not polymorphic and is lacking this repeat array) their function in the development of human breast cancer has remained elusive. Here it is shown that these MUC1 proteins are extensively phosphorylated, that phosphorylation occurs primarily on tyrosine residues and that following phosphorylation the MUC1 proteins may potentially interact with SH2 domain-containing proteins and thereby initiate a signal transduction cascade. As with cytokine receptors, the MUC1 proteins do not harbor intrinsic tyrosine kinase activity yet are tyrosine phosphorylated and the MUC1/Y protein participates in a cell surface heteromeric complex whose formation is mediated by two cytoplasmically located MUC1 cysteine residues. Furthermore, the MUC1/Y protein demonstrates sequence similarity with sequences present in cytokine receptors that are known to be involved in ligand binding. Our results demonstrate that the two MUC1 isoforms are both likely to function in signal transduction pathways and to be intimately linked to the oncogenetic process and suggest that the MUC1/Y protein may act in a similar fashion to cytokine receptors.
酪氨酸残基的磷酸化是膜蛋白介导的信号转导途径中的关键步骤。尽管已知人类乳腺癌组织表达至少两种MUC1 1型膜蛋白(一种含有可变数量串联20个氨基酸重复单元的多态性高分子量MUC1糖蛋白,以及非多态性且缺乏此重复序列的MUC1/Y蛋白),但它们在人类乳腺癌发生发展中的功能仍不清楚。本文表明,这些MUC1蛋白被广泛磷酸化,磷酸化主要发生在酪氨酸残基上,磷酸化后MUC1蛋白可能与含SH2结构域的蛋白相互作用,从而启动信号转导级联反应。与细胞因子受体一样,MUC1蛋白不具有内在的酪氨酸激酶活性,但能被酪氨酸磷酸化,且MUC1/Y蛋白参与一种细胞表面异聚体复合物的形成,该复合物的形成由两个位于细胞质中的MUC1半胱氨酸残基介导。此外,MUC1/Y蛋白与已知参与配体结合的细胞因子受体中的序列具有序列相似性。我们的结果表明,两种MUC1异构体都可能在信号转导途径中发挥作用,并与肿瘤发生过程密切相关,提示MUC1/Y蛋白可能以与细胞因子受体类似的方式发挥作用。